Biotech Values

[DewDiligence]

Kyowa Kirin—>testing cancer drug, tivozanib as_an eyedrop for AMD:

https://www.prnewswire.com/news-releases/kyowa-kirin-announces-acceptance-of-abstract-for-presentation-at-the-association-for-research-in-vision-and-ophthalmology-annual-meeting-2024-302106101.html

I’m pretty skeptical that an eyedrop can work for a back-of-the-eye-disease like AMD, but it would be awesome if it did.

Tivozanib, under the brand name Fotivda, was FDA-appoved for RCC in 2021 (#msg-162474260).